Status:
UNKNOWN
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
Lead Sponsor:
National Nutrition and Food Technology Institute
Conditions:
Peritoneal Dialysis Patients
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this double-blind randomized clinical trial is to determine the effects of isoflavones on cardiovascular disease risk factors, bone metabolism markers, serum concentrations of fructoseamine...
Eligibility Criteria
Inclusion
- Continuous Ambulatory Peritoneal Dialysis for 6 months or more Body mass index below 35
Exclusion
- infections inflammatory diseases; liver diseases; past medical history of cancer receiving glucocorticoid and anti-inflammatory drugs receiving isoflavone supplements Constant consumption of soy or foods containing soy in the diet
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT03773029
Start Date
January 1 2019
End Date
November 1 2019
Last Update
November 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Nutrition and Food Technology Research Institute
Tehran, Iran (the Islamic Republic Of), Iran, 1981619573